Submitted by Anonymous (not verified) on 29 July 2024 - 16:30
Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 2, Status: Authorised